1. Home
  2. RIBB vs SLP Comparison

RIBB vs SLP Comparison

Compare RIBB & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIBB
  • SLP
  • Stock Information
  • Founded
  • RIBB 2024
  • SLP 1996
  • Country
  • RIBB Japan
  • SLP United States
  • Employees
  • RIBB N/A
  • SLP N/A
  • Industry
  • RIBB
  • SLP EDP Services
  • Sector
  • RIBB
  • SLP Technology
  • Exchange
  • RIBB NYSE
  • SLP Nasdaq
  • Market Cap
  • RIBB 64.9M
  • SLP 708.1M
  • IPO Year
  • RIBB 2025
  • SLP 1997
  • Fundamental
  • Price
  • RIBB $10.04
  • SLP $30.25
  • Analyst Decision
  • RIBB
  • SLP Buy
  • Analyst Count
  • RIBB 0
  • SLP 8
  • Target Price
  • RIBB N/A
  • SLP $47.83
  • AVG Volume (30 Days)
  • RIBB 10.1K
  • SLP 473.5K
  • Earning Date
  • RIBB 01-01-0001
  • SLP 07-01-2025
  • Dividend Yield
  • RIBB N/A
  • SLP 0.20%
  • EPS Growth
  • RIBB N/A
  • SLP N/A
  • EPS
  • RIBB N/A
  • SLP 0.36
  • Revenue
  • RIBB N/A
  • SLP $78,564,000.00
  • Revenue This Year
  • RIBB N/A
  • SLP $30.38
  • Revenue Next Year
  • RIBB N/A
  • SLP $11.97
  • P/E Ratio
  • RIBB N/A
  • SLP $84.56
  • Revenue Growth
  • RIBB N/A
  • SLP 21.49
  • 52 Week Low
  • RIBB $9.95
  • SLP $23.01
  • 52 Week High
  • RIBB $10.45
  • SLP $51.22
  • Technical
  • Relative Strength Index (RSI)
  • RIBB N/A
  • SLP 46.07
  • Support Level
  • RIBB N/A
  • SLP $27.85
  • Resistance Level
  • RIBB N/A
  • SLP $36.45
  • Average True Range (ATR)
  • RIBB 0.00
  • SLP 1.68
  • MACD
  • RIBB 0.00
  • SLP -0.74
  • Stochastic Oscillator
  • RIBB 0.00
  • SLP 27.91

About RIBB RIBBON ACQUISITION CORP

Ribbon Acquisition Corp is a blank check company.

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Share on Social Networks: